Detalles de la búsqueda
1.
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials.
Hematol Oncol
; 40(5): 1009-1019, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638723
2.
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).
Ann Hematol
; 100(2): 429-436, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161453
3.
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials.
Haematologica
; 105(4): 1074-1080, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31248973
4.
Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma.
Blood
; 127(9): 1102-8, 2016 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26729895
5.
Age and organ damage correlate with poor survival in myeloma patients: meta-analysis of 1435 individual patient data from 4 randomized trials.
Haematologica
; 98(6): 980-7, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23445873
6.
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study.
Blood
; 115(10): 1873-9, 2010 Mar 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-19965659
7.
Minimal residual disease and log-reduction of plasma cells are associated with superior response after double autologous stem cell transplant in younger patients with multiple myeloma.
Cytometry B Clin Cytom
; 96(3): 195-200, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30549231
8.
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial.
J Hematol Oncol
; 12(1): 4, 2019 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626425
9.
Treatment Intensification With Autologous Stem Cell Transplantation and Lenalidomide Maintenance Improves Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma in Complete Response.
Clin Lymphoma Myeloma Leuk
; 18(8): 533-540, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29910180
10.
Ruxolitinib - better prognostic impact in low-intermediate 1 risk score: evaluation of the 'rete ematologica pugliese' (REP) in primary and secondary myelofibrosis.
Leuk Lymphoma
; 58(1): 138-144, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27263544
11.
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Blood Cancer J
; 11(12): 197, 2021 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34876566
12.
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.
Leuk Lymphoma
; 60(14): 3565-3568, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286780
13.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: updated follow-up and improved survival.
J Clin Oncol
; 32(7): 634-40, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24449241
14.
Lenalidomide can induce long-term responses in patients with multiple myeloma relapsing after multiple chemotherapy lines, in particular after allogeneic transplant.
Leuk Lymphoma
; 52(7): 1262-70, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21534872
15.
Bortezomib-melphalan-prednisone-thalidomide followed by maintenance with bortezomib-thalidomide compared with bortezomib-melphalan-prednisone for initial treatment of multiple myeloma: a randomized controlled trial.
J Clin Oncol
; 28(34): 5101-9, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20940200
Resultados
1 -
15
de 15
1
Próxima >
>>